|
Beryl Drugs Ltd.
|
Nine Months RESULTS
|
|
|
You can view the
Nine Months Results
for the last 5 years.
|
Market Cap. (Rs.)
|
8.87 Cr.
|
P/BV
|
1.00
|
Book Value (Rs.)
|
17.55
|
|
52 Week High/Low (Rs.)
|
46/17
|
FV/ML
|
10/1
|
P/E(X)
|
11.54
|
|
Bookclosure
|
30/09/2024
|
EPS (Rs.)
|
1.52
|
Div Yield (%)
|
0.00
|
|
(Rs. in Crs.)
| Net Sales/Income from operations | 11.70 |
| Other Operating Income | 0.06 |
| Total Income From Operations | 11.76 |
| | |
| EXPENDITURE | |
| Consumption of Raw Materials | 7.49 |
| Increase/Decrease in Stocks | 1.22 |
| Employees Cost | 0.55 |
| Depreciation | 0.30 |
| Other Expenses | 1.80 |
| Total Expenses | 11.35 |
| | |
| P/L Before Other Inc. , Int., Excpt. Items & Tax | 0.41 |
| P/L Before Interest, Excpt. Items & Tax | 0.41 |
| Interest | 0.09 |
| P/L Before Exceptional Items & Tax | 0.31 |
| P/L Before Tax | 0.31 |
| Tax | 0.09 |
| P/L After Tax from Ordinary Activities | 0.22 |
| Extra Ordinary Item | 0.46 |
| Net Profit/Loss For the Period | 0.68 |
| Net P/L After Minority Interest & Share Of Associates | 0.68 |
| | |
| Equity Share Capital | 5.07 |
| EPS Before Extra Ordinary * | |
| Basic EPS (Rs.) | 0.62 |
| Diluted EPS (Rs.) | 0.62 |
| EPS After Extra Ordinary * | |
| Basic EPS (Rs.) | 0.62 |
| Diluted EPS (Rs.) | 0.62 |
| | |
| PBITOE Margin (%) | 3.44 |
| PBTE Margin (%) | 2.67 |
| PBT Margin (%) | 2.67 |
| PAT Margin (%) | 5.77 |
| PAT After MI And SOA Margin (%) | 5.77 |
